Investor Stock List
Ranked #4,553 of 8,699 institutional investors

Elmind Capital, LP

New York, NY

$351M
US stock portfolio at live prices · today +$1.0M (+0.30%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$404M
Change from Q2 2026
+$5.8M (+1.46%)
Positions
27 · 0 new, 5 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$37.4M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
VRDN 11.0%CLDX 8.84%LEGN 7.20%COGT 6.85%AMLX 6.68%
StockSharesValue, live% of portfoliovs Q2 2026
VRDN Viridian Therapeutics, Inc.1,224,931$38.5M11.0%Added +24%
CLDX Celldex Therapeutics, Inc.1,110,000$31.0M8.84%Added +12%
LEGN Legend Biotech Corporation1,569,676$25.3M7.20%Added +175%
COGT Cogent Biosciences, Inc.866,742$24.0M6.85%Reduced −26%
AMLX Amylyx Pharmaceuticals, Inc.894,760$23.4M6.68%Added +699%
RLAY Relay Therapeutics, Inc.1,465,279$23.3M6.64%Unchanged
PCVX Vaxcyte, Inc.372,340$21.7M6.19%Reduced −18%
TVTX Travere Therapeutics, Inc.322,600$15.6M4.44%Added +10%
SNDX Syndax Pharmaceuticals, Inc.1,605,000$14.7M4.17%Reduced −13%
VERA Vera Therapeutics, Inc.436,518$11.7M3.33%Unchanged
BEAM Beam Therapeutics Inc.476,338$10.0M2.84%Unchanged
CTMX CytomX Therapeutics, Inc.4,550,000$9.3M2.66%Unchanged
CGEM Cullinan Therapeutics, Inc.962,792$8.7M2.49%Added +40%
UTHR United Therapeutics Corporation15,000$8.4M2.39%Unchanged
KRYS Krystal Biotech, Inc.22,000$6.9M1.98%Unchanged
IMCR Immunocore Holdings plc256,143$6.8M1.94%Added +216%
NRIX Nurix Therapeutics, Inc.460,000$6.3M1.78%Unchanged
SMMT Summit Therapeutics Inc.493,820$5.2M1.49%Unchanged
BCRX BioCryst Pharmaceuticals, Inc.520,000$3.8M1.08%Unchanged
MBX MBX Biosciences, Inc.61,000$3.3M0.93%Reduced −33%
ALMS Alumis Inc.749,560$3.2M0.92%Added +477%
BMRN BioMarin Pharmaceutical Inc.47,000$2.9M0.82%Unchanged
DBVT DBV Technologies S.A.265,000$2.5M0.71%Unchanged
ALEC Alector, Inc.915,902$2.1M0.60%Added +2%
STRO Sutro Biopharma, Inc.228,265$2.0M0.57%Added +613%
SEPN Septerna, Inc.49,444$1.9M0.55%Unchanged
DSGN Design Therapeutics, Inc.107,900$1.0M0.29%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
INSM Insmed Incorporated65,000$9.4M
PTGX Protagonist Therapeutics, Inc.38,000$4.7M
WVE Wave Life Sciences, Inc.177,846$484K
TYRA Tyra Biosciences, Inc.20,000$395K
ENGN enGene Therapeutics Inc.210,000$370K